Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage
Open Access
- 1 May 2005
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 36 (5), 1011-1015
- https://doi.org/10.1161/01.str.0000160801.96998.57
Abstract
Background and Purpose— Magnesium reverses cerebral vasospasm and reduces infarct volume after experimental subarachnoid hemorrhage (SAH) in rats. We aimed to assess whether magnesium reduces the frequency of delayed cerebral ischemia (DCI) in patients with aneurysmal SAH. Methods— Patients were randomized within 4 days after SAH. Magnesium sulfate therapy consisted of a continuous intravenous dose of 64 mmol/L per day, to be started within 4 days after SAH and continued until 14 days after occlusion of the aneurysm. The primary outcome DCI (defined as the occurrence of a new hypodense lesion on computed tomography compatible with clinical features of DCI) was analyzed according to the “on-treatment” principle. For the secondary outcome measures “poor outcome” (Rankin >3) and “excellent outcome” (Rankin 0), we used the “intention-to-treat” principle. Results— A total of 283 patients were randomized. Magnesium treatment reduced the risk of DCI by 34% (hazard ratio, 0.66; 95% CI, 0.38 to 1.14). After 3 months, the risk reduction for poor outcome was 23% (risk ratio, 0.77; 95% CI, 0.54 to 1.09). At that time, 18 patients in the treatment group and 6 in the placebo group had an excellent outcome (risk ratio, 3.4; 95% CI, 1.3 to 8.9). Conclusions— This study suggests that magnesium reduces DCI and subsequent poor outcome, but the results are not yet definitive. A next step should be a phase III trial to confirm the beneficial effect of magnesium therapy, with poor outcome as primary outcome.Keywords
This publication has 19 references indexed in Scilit:
- Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatmentActa Neurochirurgica, 2003
- Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhageJournal of Neurosurgery, 2002
- Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhageJournal of Clinical Neuroscience, 2002
- Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 2002
- Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhageNeurology, 2000
- Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemiaJournal of Neurosurgery, 1996
- Magnesium and its therapeutic uses: A reviewAmerican Journal Of Medicine, 1994
- The International Cooperative Studyon the Timing of Aneurysm SurgeryJournal of Neurosurgery, 1990
- Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channelsBiophysical Journal, 1990
- Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageNeurology, 1986